{{Rsnum
|rsid=750155
|Gene=SULT1A1
|Chromosome=16
|position=28609251
|Orientation=plus
|GMAF=0.4008
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SULT1A1
}}{{PharmGKB
|RSID=rs750155
|Name_s=SULT1A1: -396 G>A
|Gene_s=SULT1A1
|Feature=Intron
|Evidence=PubMed ID:15970794
|Annotation=This promoter region SNP is tightly linked to the *2 variant and may be responsible for some of the functional effects that have been attributed to *2. It has been associated with decreased platelet SULT1A1 activity in African-Americans and increased activity in Caucasians.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA161845824
}}

{{PharmGKB
|RSID=rs750155
|Name_s=SULT1A1:-396 G>A
|Gene_s=SULT1A1
|Feature=Intron
|Evidence=Web Resource:http://www.pharmgkb.org/search/annotatedGene/sult1a1/variant.jsp
|Annotation=Associated with a population-dependent increase or decrease in activity.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=In-Depth
|PharmGKB Accession ID=PA161145155
}}{{PMID Auto
|PMID=19287157
|Title=Sulfotransferase gene copy number variation: pharmacogenetics and function.
|OA=1
}}{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs750155
|overall_frequency_n=30
|overall_frequency_d=78
|overall_frequency=0.384615
|n_genomes=23
|n_genomes_annotated=0
|n_haplomes=27
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}